82 related articles for article (PubMed ID: 15628799)
1. [Clinical and bacteriological substantiation of the use of cefoperazone/sulbactam in complex therapy of patients with pyo-destructive forms of lower respiratory tract infection (LRTI)].
Ovsiankin AV; Mukonin AA
Antibiot Khimioter; 2004; 49(6):25-9. PubMed ID: 15628799
[TBL] [Abstract][Full Text] [Related]
2. [Clinical efficacy of sulbactam/cefoperazone for the treatment of geriatric patients with respiratory tract infections].
Takaki K; Umeno M; Tanaka M; Harashima S; Takeda T; Okada K; Sawae Y
Jpn J Antibiot; 1995 Jul; 48(7):942-8. PubMed ID: 7563587
[TBL] [Abstract][Full Text] [Related]
3. [Clinical evaluation of combination therapy of sulbactam/cefoperazone and aminoglycoside in respiratory tract infections].
Sukoh M; Inoue T; Morita Y; Ito K; Togano Y; Yamanaka K; Hirose S; Takahashi T; Mita S; Mano K
Jpn J Antibiot; 1994 Feb; 47(2):170-80. PubMed ID: 8151910
[TBL] [Abstract][Full Text] [Related]
4. Cefoperazone-sulbactam for treatment of intra-abdominal infections: results from a randomized, parallel group study in India.
Chandra A; Dhar P; Dharap S; Goel A; Gupta R; Hardikar JV; Kapoor VK; Mathur AK; Modi P; Narwaria M; Ramesh MK; Ramesh H; Sastry RA; Shah S; Virk S; Sudheer OV; Sreevathsa MR; Varshney S; Kochhar P; Somasundaram S; Desai C; Schou M
Surg Infect (Larchmt); 2008 Jun; 9(3):367-76. PubMed ID: 18570578
[TBL] [Abstract][Full Text] [Related]
5. [Effects of sulbactam/cefoperazone in patients with respiratory infections in aged and/or with underlying respiratory diseases].
Akutsu I; Motojima S; Sagara H; Ogata H; Otsuka T; Fukuda T; Ikemori R; Makino S
Jpn J Antibiot; 1989 Apr; 42(4):910-20. PubMed ID: 2769942
[TBL] [Abstract][Full Text] [Related]
6. [Clinical experience with the treatment of severe nosocomial infections by inhibitor-protected 3rd generation cephalosporin cefoperazone/sulbactam].
Beloborodova NV; Kuznetsova ST; Popov DA; Bachinskaia EN; Vostrikov TIu
Antibiot Khimioter; 2005; 50(4):33-40. PubMed ID: 16392338
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy of cefoperazone, cefoperazone plus sulbactam, ciprofloxacin, clindamycin, metronidazole, and penicillin G against anaerobic bacteria in an animal model.
Moody JA; Fasching CE; Sinn LM; Gerding DN; Peterson LR
J Lab Clin Med; 1990 Feb; 115(2):190-5. PubMed ID: 1967626
[TBL] [Abstract][Full Text] [Related]
8. In vitro assessment of sulbactam plus cefoperazone in the treatment of bacteria isolated from cancer patients.
Bodey GP; Miller P; Ho DH
Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):209S-214S. PubMed ID: 2591178
[TBL] [Abstract][Full Text] [Related]
9. [Cefoperazone/sulbactam in continuous infusion].
Woźnica R; Ferenc K; Kurec D
Anestezjol Intens Ter; 2010; 42(2):80-4. PubMed ID: 21413432
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy and safety of cefoperazone/sulbactam in the treatment of children with mucoviscidosis during exacerbation of the bronchopulmonary process].
Semykin SIu; Postnikov SS; Polikarpova SV; Perederko LV
Antibiot Khimioter; 2003; 48(12):18-21. PubMed ID: 15176099
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic effects of cefepime and sulbactam/cefoperazone on moderate and severe respiratory tract infection in children].
Huang JJ; Zeng Q; Yu JL
Di Yi Jun Yi Da Xue Xue Bao; 2005 Sep; 25(9):1199-200. PubMed ID: 16174597
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis and therapy of abscess forming pneumonia].
Allewelt M; Lode H
Ther Umsch; 2001 Oct; 58(10):599-603. PubMed ID: 11695090
[TBL] [Abstract][Full Text] [Related]
13. Randomized Noninferiority Trial of Cefoperazone-Sulbactam versus Cefepime in the Treatment of Hospital-Acquired and Healthcare-Associated Pneumonia.
Liu JW; Chen YH; Lee WS; Lin JC; Huang CT; Lin HH; Liu YC; Chuang YC; Tang HJ; Chen YS; Ko WC; Lu MC; Wang FD
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31138577
[TBL] [Abstract][Full Text] [Related]
14. In-vitro susceptibility of Burkholderia pseudomallei to cefoperazone-sulbactam combination.
Koay AS; Rohani MY; Cheong YM
Med J Malaysia; 1997 Jun; 52(2):158-60. PubMed ID: 10968074
[TBL] [Abstract][Full Text] [Related]
15. Cefodizime once daily in the treatment of lower respiratory tract infections.
Piovano CF; Palombini BC; Dagrosa EE; Mendoza F; Facco EB
Arzneimittelforschung; 1997 May; 47(5):674-7. PubMed ID: 9205786
[TBL] [Abstract][Full Text] [Related]
16. [Treatment approaches for bronchopulmonary infection in myasthenia gravis patients].
Sokolova VI; Sanadze AG; Sychev DA; Babarina MB; Zaĭkov DA
Antibiot Khimioter; 2014; 59(1-2):20-3. PubMed ID: 25051712
[TBL] [Abstract][Full Text] [Related]
17. Comparison of piperacillin tazobactam and cefoperazone sulbactam monotherapy in treatment of febrile neutropenia.
Karaman S; Vural S; Yildirmak Y; Emecen M; Erdem E; Kebudi R
Pediatr Blood Cancer; 2012 Apr; 58(4):579-83. PubMed ID: 21674768
[TBL] [Abstract][Full Text] [Related]
18. An Italian experience of sequential intravenous and oral azithromycin plus intravenous ampicillin/sulbactam in hospitalized patients with community-acquired pneumonia.
Todisco T; Dal Farra F; Ciliberti G; Pirina P; Guelfi R; Serra G; Paris R; Mancuso I; Cepparulo M
J Chemother; 2008 Apr; 20(2):225-32. PubMed ID: 18467250
[TBL] [Abstract][Full Text] [Related]
19. [Antibacterial activity in vitro and clinical use of sulperazon].
Wang X; Shi Y; Qin W
Zhonghua Nei Ke Za Zhi; 1997 Jun; 36(6):406-10. PubMed ID: 10374302
[TBL] [Abstract][Full Text] [Related]
20. [An evaluation of a therapy with antibacterial and antifungal agents infections with hematological disorders].
Inoue N; Takemoto Y; Kanamaru A; Kakishita E; Nakayama S; Hara H; Tsutsui T; Murakami R; Yamaguchi N; Tago H
Jpn J Antibiot; 1993 Jun; 46(6):486-91. PubMed ID: 8360984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
